146 related articles for article (PubMed ID: 17371490)
21. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
22. Identification of a candidate missense mutation in a family with von Willebrand disease type IIC.
Schneppenheim R; Thomas KB; Krey S; Budde U; Jessat U; Sutor AH; Zieger B
Hum Genet; 1995 Jun; 95(6):681-6. PubMed ID: 7789955
[TBL] [Abstract][Full Text] [Related]
23. Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I.
Zhang ZP; Lindstedt M; Falk G; Blombäck M; Egberg N; Anvret M
Am J Hum Genet; 1992 Oct; 51(4):850-8. PubMed ID: 1415226
[TBL] [Abstract][Full Text] [Related]
24. Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene.
Peake IR; Bowen D; Bignell P; Liddell MB; Sadler JE; Standen G; Bloom AL
Blood; 1990 Aug; 76(3):555-61. PubMed ID: 2378985
[TBL] [Abstract][Full Text] [Related]
25. A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3.
Sutherland MS; Cumming AM; Bowman M; Bolton-Maggs PH; Bowen DJ; Collins PW; Hay CR; Will AM; Keeney S
Blood; 2009 Jul; 114(5):1091-8. PubMed ID: 19372260
[TBL] [Abstract][Full Text] [Related]
26. Von Willebrand gene tracking by single-tube automated fluorescent analysis of four short tandem repeat polymorphisms.
Vidal F; Julià A; Altisent C; Puig L; Gallardo D
Thromb Haemost; 2005 May; 93(5):976-81. PubMed ID: 15886817
[TBL] [Abstract][Full Text] [Related]
27. Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.
Borràs N; Garcia-Martínez I; Batlle J; Pérez-Rodríguez A; Parra R; Altisent C; López-Fernández MF; Costa Pinto J; Batlle-López F; Cid AR; Bonanad S; Cabrera N; Moret A; Mingot-Castellano ME; Navarro N; Pérez-Montes R; Marcellini S; Moreto A; Herrero S; Soto I; Fernández-Mosteirín N; Jiménez-Yuste V; Alonso N; de Andrés-Jacob A; Fontanes E; Campos R; Paloma MJ; Bermejo N; Berrueco R; Mateo J; Arribalzaga K; Marco P; Palomo Á; Castro Quismondo N; Iñigo B; Del Mar Nieto M; Vidal R; Martínez MP; Aguinaco R; Tenorio M; Ferreiro M; García-Frade J; Rodríguez-Huerta AM; Cuesta J; Rodríguez-González R; García-Candel F; Dobón M; Aguilar C; Corrales I; Vidal F
Thromb Haemost; 2020 Mar; 120(3):437-448. PubMed ID: 32135566
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin.
Eikenboom JC; Castaman G; Vos HL; Bertina RM; Rodeghiero F
Thromb Haemost; 1998 Apr; 79(4):709-17. PubMed ID: 9569178
[TBL] [Abstract][Full Text] [Related]
29. Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method.
Inbal A; Englender T; Kornbrot N; Randi AM; Castaman G; Mannucci PM; Sadler JE
Blood; 1993 Aug; 82(3):830-6. PubMed ID: 8338947
[TBL] [Abstract][Full Text] [Related]
30. Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease.
Schneppenheim R; Budde U; Obser T; Brassard J; Mainusch K; Ruggeri ZM; Schneppenheim S; Schwaab R; Oldenburg J
Blood; 2001 Apr; 97(7):2059-66. PubMed ID: 11264172
[TBL] [Abstract][Full Text] [Related]
31. Laboratory and molecular characteristics of recessive von Willebrand disease type 2C (2A subtype IIC) of variable severity due to homozygous or double heterozygous mutations in the D1 and D2 domains.
Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):111-8. PubMed ID: 19506357
[TBL] [Abstract][Full Text] [Related]
32. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1.
Schneppenheim R; Budde U; Krey S; Drewke E; Bergmann F; Lechler E; Oldenburg J; Schwaab R
Thromb Haemost; 1996 Oct; 76(4):598-602. PubMed ID: 8903002
[TBL] [Abstract][Full Text] [Related]
33. Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.
Casonato A; Cattini MG; Barbon G; Daidone V; Pontara E
Thromb Res; 2015 Sep; 136(3):682-6. PubMed ID: 26251079
[TBL] [Abstract][Full Text] [Related]
34. Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease.
Ahmad F; Kannan M; Biswas A; Saxena R
Ann Hematol; 2009 May; 88(5):479-83. PubMed ID: 18923835
[TBL] [Abstract][Full Text] [Related]
35. In-frame deletion of von Willebrand factor A domains in a dominant type of von Willebrand disease.
Bernardi F; Patracchini P; Gemmati D; Pinotti M; Schwienbacher C; Ballerini G; Marchetti G
Hum Mol Genet; 1993 May; 2(5):545-8. PubMed ID: 8518792
[TBL] [Abstract][Full Text] [Related]
36. Investigation of von Willebrand factor gene mutations in Korean von Willebrand disease patients.
Song J; Choi JR; Song KS
Korean J Lab Med; 2007 Jun; 27(3):169-76. PubMed ID: 18094571
[TBL] [Abstract][Full Text] [Related]
37. The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.
Bowman M; Tuttle A; Notley C; Brown C; Tinlin S; Deforest M; Leggo J; Blanchette VS; Lillicrap D; James P;
J Thromb Haemost; 2013 Mar; 11(3):512-20. PubMed ID: 23311757
[TBL] [Abstract][Full Text] [Related]
38. A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene.
Castaman G; Novella E; Castiglia E; Eikenboom JC; Rodeghiero F
Thromb Res; 2002 Jan; 105(2):135-8. PubMed ID: 11958803
[TBL] [Abstract][Full Text] [Related]
39. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.
Eikenboom JC; Matsushita T; Reitsma PH; Tuley EA; Castaman G; Briët E; Sadler JE
Blood; 1996 Oct; 88(7):2433-41. PubMed ID: 8839833
[TBL] [Abstract][Full Text] [Related]
40. Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets.
Mancuso DJ; Kroner PA; Christopherson PA; Vokac EA; Gill JC; Montgomery RR
Blood; 1996 Oct; 88(7):2559-68. PubMed ID: 8839848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
